Trial Profile
The change of cytokines in tear fluid with dry eye patients after rebamipide instillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2017
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- 25 Jul 2017 Status changed from recruiting to completed.
- 26 May 2016 New trial record